Infliximab

Details

Files

Generic Name:

Infliximab

Project Status:

Complete

Therapeutic Area:

Ulcerative Colitis

Manufacturer:

Centocor Inc.

Brand Name:

Remicade

Project Line:

Reimbursement Review

Project Number:

SR0146-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Ulcerative Colitis

Recommendation Type:

Do not list

Final Recommendation:

April 22, 2009

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : September 29, 2008